Brindavan Hospital & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 5.53 M
as on 27-06-2024
- Company Age 23 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.25 Cr
as on 27-06-2024
- Revenue 36.64%
(FY 2023)
- Profit 38.33%
(FY 2023)
- Ebitda 4.41%
(FY 2023)
- Net Worth 0.54%
(FY 2023)
- Total Assets -3.46%
(FY 2023)
About Brindavan Hospital & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 5.53 M.
The company has closed loans amounting to ₹3.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Govind Char, Vikas Char, Kalyani Govindachar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110JH2001PTC012040
- Company No.
012040
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Ramgarh, Jharkhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Brindavan Hospital & Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Malathi Char  | Managing Director | 11-Jan-2001 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Govind Char | Director | 11-Jan-2001 | Current |
| Vikas Char | Additional Director | 12-Jul-2021 | Current |
| Kalyani Govindachar | Director | 07-Nov-2002 | Current |
| Padma Char | Director | 11-Jan-2001 | Current |
Financial Performance of Brindavan Hospital & Research Centre.
Brindavan Hospital & Research Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.64% increase. The company also saw a substantial improvement in profitability, with a 38.33% increase in profit. The company's net worth moved up by a moderate rise of 0.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brindavan Hospital & Research Centre?
In 2023, Brindavan Hospital & Research Centre had a public holding of 25.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 Dec 2005 | ₹3.25 Cr | Satisfied |
How Many Employees Work at Brindavan Hospital & Research Centre?
Unlock and access historical data on people associated with Brindavan Hospital & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brindavan Hospital & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brindavan Hospital & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
